16th Apr 2020 06:59
(Alliance News) - Renalytix AI PLC on Wednesday said it has signed a provider network agreement with Three Rivers Provider Network Inc covering KidneyIntelX testing in patients with kidney disease.
KidneyIntelX combines machine learning, blood-based biomarkers and a patient's electronic health record to asses the risk of rapid kidney disease progression.
Renalytix explained that: "Under the agreement, KidneyIntelX tests processed on eligible patients through the RenalytixAI Salt Lake City Utah clinical laboratory facility are now available to both [Three Rivers] members and clients."
Three Rivers, described by Renalytix as "the largest and fastest growing proprietary provider organisation network in the US", was founded in 1996. It contracts with providers like Renalytix "to provide better healthcare value" to its members.
At present, the Three Rivers network has over 1.5 million provider locations. This includes 100,000 ancillary care facilities as well as 5,000 hospitals. Members of the network can now access KidneyIntelX risk assessment testing.
Shelley Glick, president of Market Access at Renalytix said: "A provider agreement that supports insurance coverage for a novel prognost[proprietary provider organisations] are an important avenue for many Americans to get access to high quality healthcare. Partnering with an industry leader like Three Rivers is core to our strategy of providing broad population access to KidneyIntelX."
By Anna Farley; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Renalytix Plc